Relevant to this, Mer et al., recently identified two distinct subtypes within NPM1-mutated AML patients, referred to as “primitive” or “committed”, based on the respective presence or absence of a stem cell signature [90]. This evidence concerns the gene NPM1 and acute myeloid leukemia.